Shennon Biotechnologies
Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.
$12MFunding
ParticipantActivity from announced rounds
Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.
SciFin gives enterprise revenue teams a continuously updated view of accounts, deals, forecasts, territories and customer conversations. Its AI companion, Pixie, uses that connected context to answer business questions, identify risks, prepare reports and recommend follow-up actions.
Pitching Foundation Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room